Antidepressants and Sexual Dysfunction (1)

Sexual side effects of medication can be problematic for patients and, if they occur, often impact their well-being and relationships in significant ways. Common treatment options are switching the psychotropic medication, adding psychotropic or non-psychotropic medication and psychotherapeutic approaches.

Keywords: suicide, treatment, psychotherapy, medication, psychiatry

 

For the full article please click on the following link:

Antidepressants and Sexual Dysfunction (1) Ch Jonathan Haverkampf

Psychiatric Medication – Weight Gain and the Metabolic Syndrome (1)

About 60% of the excess mortality observed in patients with severe mental illness (SMI), such as schizophrenia, bipolar disorder and major depressive disorder (MDD), is due to physical comorbidities, predominantly cardiovascular diseases. Weight gain and the metabolic syndrome are undesired effects of psychiatric medication, which ultimately can limit the use of a drug. Frequently, the decision whether to continue or switch a drug is not easy to make, and carefully weighing off the benefits and potential problems should be part of an informed treatment strategy.

Keywords: obesity, metabolic syndrome, medication, psychiatry

 

For the full article please click on the following link:

Psychiatric Medication – Weight Gain and the Metabolic Syndrome (1) Ch Jonathan Haverkampf

A Brief Overview of Psychiatric Medication (4)

Abstract – This article gives a brief overview of the main groups of psychiatric medication.

 

Keywords: medication, psychiatry

 

For the full article please click on the following link:

A Brief Overview of Psychiatric Medication (4) Ch Jonathan Haverkampf

Depression and Medication (3)

Depression is the medical condition with one of the highest prevalence rates, but also one of the costliest ones in terms of human suffering, missed work hours, higher mortality and the higher incidence of physical illnesses. First-line treatment is usually a combination of medication and psychotherapy. In milder cases, psychotherapy alone may be sufficient, while in very severe cases, psychotherapy may not be possible. Antidepressants from a number of functional families are available, with the serotonin reuptake inhibitors (SSRIs) being the mostly used ones, followed by the serotonin and norepinephrine reuptake inhibitors (SNRIs) and antidepressants from other groups. In cases of treatment resistance, an increase in the dose, or if this is not possible a switch to a different group of antidepressants may be necessary. Rarely is a combination therapy needed. Selection of an antidepressant depends on the specific symptoms, such as insomnia or reduced activity, the patient’s current situation, including pregnancy or a requirement for alertness on the job, and many other factors, including past episodes of depression and the medication history.

Keywords: depression, medication, psychiatry

 

 

For the article click here:

Depression and Medication (3) Ch Jonathan Haverkampf

 


Dr Jonathan Haverkampf, M.D. MLA (Harvard) LL.M. trained in medicine, psychiatry and psychotherapy and works in private practice for psychotherapy, counselling and psychiatric medication in Dublin, Ireland. He also has advanced degrees in management and law. The author can be reached by email at jonathanhaverkampf@gmail.com or on the website www.jonathanhaverkampf.ie.

This article is solely a basis for academic discussion and no medical advice can be given in this article, nor should anything herein be construed as advice. Always consult a professional if you believe you might suffer from a physical or mental health condition. Neither author nor publisher can assume any responsibility for using the information herein.

Trademarks belong to their respective owners. No checks have been made. 

© 2012-2017 Christian Jonathan Haverkampf. All Rights Reserved

Unauthorized reproduction and/or publication in any form is prohibited.

Panic Attacks and Medication (2)

Panic attacks can interfere greatly with a patient’s social, professional and personal life. The first-line treatment is usually a combination of psychotherapy and medication. Medication broadly addresses two time horizons. In the short-run, benzodiazepines or benzodiazepine-like drugs reduces anxiety within twenty minutes to an hour, which is too long to treat an acute panic attack biologically, but which gives the patient a greater sense of control over the feelings of anxiety, which can in turn reduce anxiety and panic attacks. In the medium- to long-run, antidepressants with effectiveness on serotonergic pathways reduce or eliminate anxiety and the occurrence of panic attacks in the majority of patients. The group of selective serotonin reuptake inhibitors (SSRIs) is probably the best researched and clinically most widely used family of antidepressants for cases of anxiety and panic attack disorders.

Keywords: panic attack, medication, psychiatry

 

Click here for the article:

Panic Attacks and Medication (2) Ch Jonathan Haverkampf

 

 


Dr Jonathan Haverkampf, M.D. MLA (Harvard) LL.M. trained in medicine, psychiatry and psychotherapy and works in private practice for psychotherapy, counselling and psychiatric medication in Dublin, Ireland. He also has advanced degrees in management and law. The author can be reached by email at jonathanhaverkampf@gmail.com or on the websites www.jonathanhaverkampf.ie and www.jonathanhaverkampf.com.

This article is solely a basis for academic discussion and no medical advice can be given in this article, nor should anything herein be construed as advice. Always consult a professional if you believe you might suffer from a physical or mental health condition. Neither author nor publisher can assume any responsibility for using the information herein.

Trademarks belong to their respective owners. No checks have been made. 

© 2012-2017 Christian Jonathan Haverkampf. All Rights Reserved

Unauthorized reproduction and/or publication in any form is prohibited.

Off-Label Medications May Help Patients With Cannabis Use Disorder

Cannabis is the most widely used illicit drug in the United States. Social and policy trends, as reflected in national surveys and state legislation, demonstrate increasing acceptance and use of cannabis with decreasing perception of harm, which may lead to an increased occurrence of cannabis use disorder. As with other substance use disorders, cannabis use disorder commonly co-occurs with non-substance-related psychiatric disorders, putting all psychiatrists at the frontlines to identify and treat patients with this disorder.

There are no FDA-approved medications for the treatment of cannabis use disorder, and few individuals who receive behavioral interventions are able to achieve sustained abstinence (Gates et al., 2016). However, several clinical trials in adults provide evidence for the off-label use of medications in the treatment of the disorder.

The current strategies for the off-label treatment of cannabis use disorder target withdrawal symptoms, aim to initiate abstinence and prevent relapse or reduce use, and treat psychiatric comorbidity and symptoms that may contribute to cannabis use. Here, we focus on the evidence supporting these key strategies. …

See full article at PsychiatricNews at http://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2016.PP12a1